Literature DB >> 7249394

IgG rheumatoid factor, complement and immune complexes in rheumatoid synovitis and vasculitis: comparative and serial studies during cytotoxic therapy.

D G Scott, P A Bacon, C Allen, C J Elson, T Wallington.   

Abstract

IgG and IgM rheumatoid factors (IgG-RF and IgM-RF), complement and three assays for immune complexes were measured in 22 patients with rheumatoid arthritis (RA) complicated by either chronic active synovitis or vasculitis. Patients with vasculitis had relatively inactive arthritis but had higher titres of rheumatoid factors, especially IgG-RF, anticomplementary activity (ACA) and lower levels of C4 than those with synovitis. Clq-binding and platelet aggregation (PA) levels were similar in both groups. Serial measurements during cytotoxic therapy showed a close temporal relationship between the clinical features of vasculitis and levels of IgG-RF, ACA and C4 both with remission and with relapse. We suggest that immune complexes containing IgG-RF which activate complement and are detected by ACA are useful markers of rheumatoid vasculitis and may be important in its pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7249394      PMCID: PMC1537119     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  24 in total

1.  Immunopathologic study of sural nerves in rheumatoid arthritis.

Authors:  D L Conn; F C McDuffie; P J Dyck
Journal:  Arthritis Rheum       Date:  1972 Mar-Apr

2.  Measurement of pain.

Authors:  E C Huskisson
Journal:  Lancet       Date:  1974-11-09       Impact factor: 79.321

3.  Activation of the complement system in rheumatoid synovitis.

Authors:  S Ruddy; K F Austen
Journal:  Fed Proc       Date:  1973-02

4.  A study of the relation of seronegative and seropositive rheumatoid arthritis to each other and to necrotizing vasculitis.

Authors:  E S Mongan; R M Cass; R F Jacox; J H Vaughen
Journal:  Am J Med       Date:  1969-07       Impact factor: 4.965

5.  IgM rheumatoid factor and low molecular weight IgM. An association with vasculitis.

Authors:  A N Theofilopoulos; G Burtonboy; J J LoSpalluto; M Ziff
Journal:  Arthritis Rheum       Date:  1974 May-Jun

6.  Hypocomplementemia in rheumatoid arthritis.

Authors:  G G Hunder; F C McDuffie
Journal:  Am J Med       Date:  1973-04       Impact factor: 4.965

7.  Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis.

Authors:  D M Ritchie; J A Boyle; J M McInnes; M K Jasani; T G Dalakos; P Grieveson; W W Buchanan
Journal:  Q J Med       Date:  1968-07

8.  General methods for the study of cells and serum during the immune response: the response to dinitrophenyl in mice.

Authors:  N R Klinman; R B Taylor
Journal:  Clin Exp Immunol       Date:  1969-04       Impact factor: 4.330

9.  The complement system in rheumatoid synovitis. I. An analysis of complement component activities in rheumatoid synovial fluids.

Authors:  S Ruddy; K F Austen
Journal:  Arthritis Rheum       Date:  1970 Nov-Dec

10.  Serum complement levels in rheumatoid arthritis. A longitudinal study of 43 cases with correlation of clinical and serological data including rheumatoid factor and thermolabile inhibitor of the F-II L.P. test.

Authors:  A F Schubart; R W Ewald; W C Schroeder; H J Rothschild; D N Bhatavadekar; P K Pullen
Journal:  Ann Rheum Dis       Date:  1965-09       Impact factor: 19.103

View more
  39 in total

1.  Incidence and predictors of severe extra-articular disease manifestations in an early rheumatoid arthritis inception cohort.

Authors:  C Turesson; K Eberhardt; L T H Jacobsson; E Lindqvist
Journal:  Ann Rheum Dis       Date:  2007-11       Impact factor: 19.103

Review 2.  Optimisation of cyclophosphamide therapy in systemic vasculitis.

Authors:  R Richmond; T W McMillan; R A Luqmani
Journal:  Clin Pharmacokinet       Date:  1998-01       Impact factor: 6.447

3.  Detection of IgG rheumatoid factor secreting cells in autoimmune MRL/1 mice: a kinetic study.

Authors:  A Tarkowski; C Czerkinsky; L A Nilsson
Journal:  Clin Exp Immunol       Date:  1984-10       Impact factor: 4.330

4.  Nitrogen mustard in severe rheumatoid arthritis.

Authors:  R Kitt; D L Scott; B L Coulton; A J Popert
Journal:  Clin Rheumatol       Date:  1983-03       Impact factor: 2.980

5.  Enzyme immunoassay of complement-binding rheumatoid factors.

Authors:  A M Teppo; C P Maury
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

6.  Measurement of rheumatoid factors by an enzyme-linked immunosorbent assay (ELISA) and comparison with other methods.

Authors:  J L Bampton; T E Cawston; M V Kyle; B L Hazleman
Journal:  Ann Rheum Dis       Date:  1985-01       Impact factor: 19.103

7.  Serum immune complexes containing IgA appear to predict erosive arthritis in a longitudinal study in rheumatoid arthritis.

Authors:  M L Westedt; M R Daha; W M Baldwin; T Stijnen; A Cats
Journal:  Ann Rheum Dis       Date:  1986-10       Impact factor: 19.103

Review 8.  B lymphocytes and humoral immune responses in rheumatoid arthritis.

Authors:  L S De Clerck
Journal:  Clin Rheumatol       Date:  1995-09       Impact factor: 2.980

9.  Diagnostic relevance of fibronectin in cryoprecipitates.

Authors:  M W Robinson; K W Walton; D G Scott; D L Scott
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

10.  Rheumatoid vasculitis: diagnostic and therapeutic decisions.

Authors:  R S Panush; P Katz; S Longley; J Love; H Stanley
Journal:  Clin Rheumatol       Date:  1983-12       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.